(Q48220936)

9 February 2018

title

Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders (English)

1 reference

9 February 2018

0 references

1 reference

Connolly AM

1

1 reference

9 February 2018

Chez MG

2

1 reference

9 February 2018

Pestronk A

3

1 reference

9 February 2018

Arnold ST

4

1 reference

9 February 2018

Mehta S

5

1 reference

9 February 2018

Deuel RK

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

The Journal of Pediatrics

published in

1 reference

9 February 2018

volume

134

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

607-613

1 reference

9 February 2018

The neuropsychology of autism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Genetic influences and infantile autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Acquired Reversible Autistic Syndrome in Acute Encephalopathic Illness in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Depressed lymphocyte responsiveness in autistic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Antibodies to myelin basic protein in children with autistic behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Immunoreactive S100 proteins of blood immunocytes and brain cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Immune abnormalities in patients with autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Reduced natural killer cell activity in autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Detection of maternal antibodies in infantile autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Decreased plasma concentrations of the C4B complement protein in autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Strong association of the third hypervariable region of HLA-DR beta 1 with autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Immunodiagnosis and immunotherapy in autistic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Antibrain antibodies in infantile autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Intravenous immunoglobulin treatment of children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Pentoxifylline: brief review and rationale for its possible use in the treatment of autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Autism and the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

The Landau-Kleffner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Epileptic electroencephalographic abnormalities and developmental dysphasias: a study of 32 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Landau-Kleffner syndrome. An eponymic badge of ignorance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Effect of Early Corticosteroid Therapy for Landau-Kleffner Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

The Landau-Kleffner syndrome or 'acquired aphasia with convulsive disorder'. Long-term follow-up of six children and a review of the recent literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Acquired epileptiform opercular syndrome: a second case report, review of the literature, and comparison to the Landau-Kleffner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Acquired epileptic aphasia: neuropsychologic follow-up of 12 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Syndrome of acquired aphasia with convulsive disorder in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Acquired aphasia with convulsive disorder: course and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Acquired Aphasia in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Antinuclear antibodies in children with chronic nonspecific complaints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

Autism spectrum disorders in children with physical or mental disability or both. I: Clinical and epidemiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

inferred from DOI database lookup

7 January 2021

based on heuristic

A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970248-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(99)70248-9

1 reference

9 February 2018

release_nb2xwuo5abex5awblyiaafrvxy

Fatcat ID

0 references

1 reference

9 February 2018